Gallbladder carcinomas are usually asymptomatic until they reach an incurable stage. As such, early incidental detection is important, if the occasional patient is to be successfully treated. The majority (90%) are adenocarcinomas, and the remainder are squamous cell carcinomas.
Although overall uncommon, gallbladder adenocarcinoma is the most common primary biliary carcinoma and the 5th most common malignancy of the gastrointestinal tract 1.
Predominantly affects older persons with long-standing cholecystolithiasis, and as such is most common in elderly women (>60 years of age, F:M ratio = 4:1) 1,3.
Early in the course of the disease, patients are invariably asymptomatic, and as such a therapeutic window is usually missed. Eventually symptoms develop, at which time the mass is usually not resectable.
Clinical presentation depends on the direction in which the mass extends. In cases where biliary obstruction is created then jaundice is often the first presentation. If the malignancy is located in the body or fundus of the gallbladder, then extension into the liver or adjacent colon or small bowel can lead to local pain or bowel obstruction respectively.
Other symptoms include right upper quadrant pain, weight loss and anorexia.
Over 90% of cases of gallbladder cancer are adenocarcinomas. Squamous cell carcinoma account for the majority of the remainder.
Risk factors include 1:
- chronic cholecystitis
- gallstones are seen in 70-90% of cases 3-4
- familial adenomatous polyposis syndrome (FAP)
- inflammatory bowel disease (IBD)
- porcelain gallbladder
- gallbladder polyps > 1 cm that are sessile and solitary
Gallbladder adenocarcinomas present in one of three morphologies:
- intraluminal mass
- diffuse mural thickening
- mass replacing the gallbladder
- presumably the end result of progression from either 1 or 2
- most common presentation
Typically gallbladder adenocarcinomas appear as large heterogeneous masses, which may have engulfed gallstones or areas of necrosis. Patchy moderate contrast enhancement is usually seen.
Features of advanced disease include:
- intrahepatic biliary dilatation
- invasion into adjacent structures
- peritoneal carcinomatosis
- hepatic and distant metastases
Dynamic MRI considered being useful and reliable in staging of advanced gallbladder cancer. MRI combined with MRC is sensitive in detection of obstructive jaundice, liver invasion as well as liver and lymph nodes metastasis. It may be more difficult to delineate the invasion to duodenum and omental metastasis by MRI 6. Reported sensitivity rates for direct hepatic invasion and lymph node invasion on MRI can be as high as 100% and 92% respectively 7.
Treatment and prognosis
Unfortunately, due to the largely asymptomatic nature of these tumours, presentation is typically late with the majority of tumours being large, unresectable, with direct extension into adjacent structures or distant metastases present at diagnosis.
Curative resection is only possible for localised early disease, which is usually found incidentally. This is reflected in the dismal prognosis 4:
- 1 year survival: 80%
- 5 year survival: 1-5%
The differential will depend on the growth pattern of the tumour.
Intraluminal masses need to be distinguished from:
Mural thickening has a limited differential but is difficult to distinguish on imaging along. Possibilities include:
The differentials for large tumours include a number of nearby primaries with extension to the gallbladder:
- 1. Saini S, Rubin GD, Kalra MK. MDCT, a practical approach. Springer Verlag. (2006) ISBN:8847004128. Read it at Google Books - Find it at Amazon
- 2. Abbruzzese JL, Willett C. Gastrointestinal oncology. Oxford University Press, USA. (2004) ISBN:0195133722. Read it at Google Books - Find it at Amazon
- 3. Brant WE, Helms CA. Fundamentals of diagnostic radiology. Lippincott Williams & Wilkins. (2007) ISBN:0781761352. Read it at Google Books - Find it at Amazon
- 4. Eisenberg RL. Gastrointestinal radiology, a pattern approach. Lippincott Williams & Wilkins. (2003) ISBN:0781737060. Read it at Google Books - Find it at Amazon
- 5. Furlan A, Ferris JV, Hosseinzadeh K et-al. Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. AJR Am J Roentgenol. 2008;191 (5): 1440-7. doi:10.2214/AJR.07.3599 - Pubmed citation
- 6. Tseng JH, Wan YL, Hung CF et-al. Diagnosis and staging of gallbladder carcinoma. Evaluation with dynamic MR imaging. Clin Imaging. 26 (3): 177-82. Clin Imaging (link) - Pubmed citation
- 7. Schwartz LH, Black J, Fong Y et-al. Gallbladder carcinoma: findings at MR imaging with MR cholangiopancreatography. J Comput Assist Tomogr. 26 (3): 405-10. J Comput Assist Tomogr (link) - Pubmed citation
- 8. Kaza RK, Gulati M, Wig JD et-al. Evaluation of gall bladder carcinoma with dynamic magnetic resonance imaging and magnetic resonance cholangiopancreatography. Australas Radiol. 2006;50 (3): 212-7. doi:10.1111/j.1440-1673.2006.01564.x - Pubmed citation